BASi Announces Extension of Mortgage Maturity

  BASi Announces Extension of Mortgage Maturity

Business Wire

WEST LAFAYETTE, Ind. -- November 4, 2013

Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it has
negotiated a twelve month extension, until October 31, 2014, on the maturity
of its $5,255,000 mortgage that was originally scheduled to mature on October
31, 2013.

"This extension enhances our flexibility as we continue to explore
alternatives for this debt, including a sale/leaseback transaction on our
building in West Lafayette or a refinancing," said President, CEO and CFO
Jacqueline Lemke.

About Bioanalytical Systems, Inc.

BASi is a pharmaceutical development company providing contract research
services and monitoring instruments to the world's leading drug development
companies and medical research organizations. The company focuses on
developing innovative services and products that increase efficiency and
reduce the cost of taking a new drug to market. Visit for more
about BASi.

This release contains forward-looking statements that are subject to risks and
 uncertainties including, but not limited to, risks and uncertainties related
    to changes in the market and demand for our products and services, the
    development, marketing and sales of products and services, changes in
 technology, industry standards and regulatory standards, and various market
and operating risks detailed in the company's filings with the Securities and
                             Exchange Commission.


Company Contact:
Bioanalytical Systems, Inc.
President, CEO and CFO
Jacqueline Lemke
Phone: 765.497.5829
Agency Contact:
Neil Berkman
Berkman Associates
Phone: 310.477.3118
Press spacebar to pause and continue. Press esc to stop.